A targeted cancer drug niraparib, used in combination with hormone therapy, was found to reduce the risk of prostate tumor ...

For children and young adults diagnosed with osteosarcoma, a common type of bone cancer for that age group, the odds of survival can be devastatingly low (20-30%) when the disease spreads to the lungs ...

From cancer biology to proactive health management, customized care is changing patient outcomes, but what are the costs and accessibility challenges?

An international team of clinical collaborators, led by physician scientists from Dana-Farber Cancer Institute, performed a first-ever clinical test of the targeted therapy avapritinib in pediatric ...

As September concludes, the landscape of GU oncology continues to evolve, with important developments in prostate, bladder, ...

A large meta-analysis suggests fecal microbiota transplantation may help reduce depressive symptoms, especially in patients ...

A novel targeted radiation approach for a rare form of malignant tumor—the solitary fibrous tumor (SFT)—has shown significant success, achieving a near-complete response in three patients. The therapy ...

Innovative advancements in cell therapy enhance NK cells for solid tumors, aiming for effective treatments while prioritizing ...

Biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) seemed to be the most effective treatments for patients with acute psoriatic arthritis (PsA) dactylitis. In a prospective ...